Nuveen Asset Management, LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 59 filers reported holding SUTRO BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q2 2024$2,652,948
+39.1%
905,443
+168.2%
0.00%0.0%
Q1 2024$1,907,598
+106.1%
337,628
+56.5%
0.00%
Q4 2023$925,473
+25.7%
215,728
+1.7%
0.00%
Q3 2023$736,143
-25.9%
212,145
-0.7%
0.00%
Q2 2023$993,328
+90038.7%
213,619
-10.4%
0.00%
Q1 2023$1,102
-34.5%
238,461
+14.6%
0.00%
-100.0%
Q4 2022$1,682
-99.9%
208,130
-9.7%
0.00%0.0%
Q3 2022$1,280,000
+6.1%
230,604
-0.4%
0.00%
Q2 2022$1,206,000
-18.7%
231,472
+24.4%
0.00%
Q1 2022$1,483,000
-45.3%
186,132
+2.2%
0.00%
-100.0%
Q4 2021$2,711,000
-59.9%
182,200
-49.1%
0.00%
-50.0%
Q3 2021$6,767,000
-10.4%
358,261
-11.8%
0.00%0.0%
Q2 2021$7,551,000
-13.9%
406,195
+5.4%
0.00%
-33.3%
Q1 2021$8,768,000
+52.8%
385,228
+45.7%
0.00%
+50.0%
Q4 2020$5,738,000
+421.6%
264,323
+141.5%
0.00%
Q3 2020$1,100,000
+179.9%
109,441
+115.7%
0.00%
Q2 2020$393,000
-2.5%
50,735
+28.6%
0.00%
Q1 2020$403,000
+34.3%
39,441
+44.8%
0.00%
Q4 2019$300,000
+16.7%
27,239
-3.5%
0.00%
Q3 2019$257,000
+41.2%
28,234
+77.0%
0.00%
Q2 2019$182,00015,9550.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$41,527,00015.56%
Samsara BioCapital, LLC 1,675,579$38,136,0007.03%
First Light Asset Management, LLC 2,058,447$46,850,0003.11%
FRAZIER MANAGEMENT LLC 1,001,421$22,792,0001.83%
AJU IB Investment Co., Ltd. 175,000$3,983,0001.50%
Altium Capital Management LP 226,719$5,160,0001.43%
Opaleye Management Inc. 341,950$7,783,0001.14%
Parkman Healthcare Partners LLC 202,696$4,613,0001.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,331$3,171,0000.84%
Eventide Asset Management 2,370,975$53,963,0000.80%
View complete list of SUTRO BIOPHARMA INC shareholders